# Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR

Study · id `cardio:ct-nct06871774` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06871774](<https://clinicaltrials.gov/study/NCT06871774>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06871774

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT06871774. Randomized; no masking; primary purpose treatment. Start 2025-06-16 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT06871774, source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)
- Started: 2025-06-16 (actual) (ClinicalTrials.gov record NCT06871774, source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT06871774, source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT06871774, source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06871774, source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06871774-2026-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR
- Condition: Transcatheter Aortic Valve Replacement
- Intervention (Device): Single Perclose Pro vascular closure device
- Intervention (Device): Dual Perclose vascular closure device
- Lead sponsor: Wake Forest University Health Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Wake Forest University Health Sciences (`cardio:wake-forest-health-sciences`)

## Provenance

Content hash: e23115547007f44daaef916fe96c581e45fb3bec99287f37efe18cb857292ec3
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
